Healthtech Investors & VC Firms in Asia-Pacific
838 firms in this list, with a median first check of $600K. 163 of them lead rounds. Generated from verified public data and updated continuously.
Santen Pharmaceutical
OsakaSeries A–Series C
Clermont Group
SingaporeGrowth–Late Stage
EISAI CO.,LTD
TokyoSeed–Growth
FountainVest Partners
Grand CaymanGrowth–Late Stage
Greater Bay Area Homeland Development Fund
Hong KongSeed–Growth
Kaist Venture Investment Holdings
SeoulSeed–Series A
Medical Research Future Fund (MRFF)
Seed–Series A
Aflac Ventures Japan
TokyoSeed–Late Stage
AG Capital Co. Ltd.
TokyoSeed–Growth
Australian Unity Future of Healthcare Fund
MelbourneSeries A–Growth
BD Venture
DhakaPre-Seed–Series B
C-CAMP
BengaluruPre-Seed–Seed
Chow Tai Fook Enterprises
Hong KongGrowth–Late Stage
Co-Stone Capital
ShenzhenSeed–Growth
Everbright Investments
Hong KongGrowth–Late Stage
Haier HOPE / HCH innovation platform
QingdaoPre-Seed–Growth
Lanka Ventures PLC
ColomboSeed
MYSC
SeongdongPre-Seed–Series A
SAIF Partners China
BeijingSeed–Growth
SDIC Venture Capital / SDIC Fund Management
BeijingSeed–Growth
Sinovation Ventures Australia
MelbournePre-Seed
Tai Partners
ShanghaiSeed–Series B
WM Partners
Growth–Late Stage
X Venture Holdings
Hong KongPre-Seed–Seed
Related lists
Investors & VC Firms in North America (13013)Investors & VC Firms in United States (12149)Investors & VC Firms in Europe (5511)Crypto & Web3 Investors & VC Firms (4820)Investors & VC Firms in Global (4182)SaaS Investors & VC Firms (3878)AI & Machine Learning Investors & VC Firms (3817)Fintech Investors & VC Firms (3738)Investors & VC Firms in Asia-Pacific (3570)Healthtech Investors & VC Firms (3445)
Data sourced from public filings and firms' own websites — see our methodology.